Biotech Style Options
These are not live design changes. They are steering options for later, built to help us choose a more distinctive visual language for CVC without drifting into generic SaaS.
Option A
A networked evidence aesthetic. Use subtle signal nodes, pathway lines, and layered blue-green tones to make CVC feel like a decision network rather than a directory.
Homepage, Why CVC, compare, and sponsor workflow pages.
Signal maps, connection nodes, route lines, structured overlays.
Option B
A more premium biotech-report feel. Strong editorial hierarchy, pale layered cards, and map-like section framing that feels strategic rather than app-heavy.
Vendor pages, policy pages, and content-heavy review areas.
Contour lines, atlas frames, research-report composition.
Option C
A sharper clinical-operations look. White surfaces, clearer grid logic, tighter spacing, and small data-like accents that make workflows feel more precise and analytical.
Review form, sponsor RFP, admin, and data-heavy operational pages.
Grid overlays, assay bars, chart fragments, compact metric chips.
Option D
A more expressive biotech-commercial route. Keep enterprise trust, but add flowing molecular-style forms and stronger amber/blue contrast for pages tied to vendor growth and sponsor support.
For Vendors, vendor subscription, sponsor support, and commercial routes.
Organic pathway curves, orbiting nodes, premium CTA emphasis.
How to steer later
Tell me the option letter and the page group: homepage, vendor pages, sponsor pages, or policy pages.
For example: “Use Clinical Atlas for vendor pages, but Molecular Flow for vendor-commercial routes.”
Signal Mesh for homepage / sponsor routes, Clinical Atlas for vendor and policy pages, Molecular Flow only for commercial vendor surfaces.
